Document is current
Any future updates will be listed below
-
Authors
Sabbagh, Quentin
Ruiz-Pallares, Nathalie
Rastin, Cassandra
Puechberty, Jacques
Guignard, Thomas
Jeandel, Claire
Merklen, Fanny
Pujol, Pascal
Kerkhof, Jennifer
Sadikovic, Bekim
Barat-Houari, Mouna
Geneviève, David
-
Funding
Funding for this research was provided by:
Genome Canada Genomic Applications Partnership Program Grant
French Ministry of Health
- License Information
-
More Information
Article History
Received: 19 November 2024
Accepted: 9 April 2025
First Online: 29 April 2025
Declarations
:
: This research protocol has been validated by the ethics committee (CPP) of the French national research program (PHRC AOM-09-070; ClinicalTrial.gov ID: NCT01314534). Written consent was further received from the family for participation in the study and publication of photographs. Clinical examination, molecular analyses, and DNA methylation profiling were performed as part of routine care.
: Please see above.
: Bekim Sadikovic is a shareholder in EpiSign Inc., a biotech company involved in commercial uses of EpiSignTM technologies.
